The class of chemicals termed Zfp469 Inhibitors encompasses a range of compounds that can indirectly influence the function of Zfp469 by altering DNA-protein interactions or the transcriptional regulation machinery. This group includes DNA methyltransferase inhibitors such as 5-Azacytidine, which can change the methylation status of DNA and potentially impact Zfp469's ability to bind DNA. Histone deacetylase inhibitors like Trichostatin A and SAHA can modify chromatin structure, which may affect the accessibility of Zfp469 to its target DNA sequences.
DNA intercalating agents like Chloroquine and Daunorubicin can disrupt DNA replication and transcription processes, thereby potentially altering the activity of Zfp469 which functions in the context of DNA. Mithramycin A and Echinomycin bind to specific DNA sequences, potentially blocking the binding sites for Zfp469 and inhibiting its function. Additionally, Actinomycin D and α-Amanitin target the transcriptional machinery by inhibiting RNA polymerase, which can have downstream effects on the transcriptional regulatory activities of Zfp469.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
Inhibits DNA methyltransferases, altering DNA methylation and potentially affecting Zfp469 binding to DNA. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Inhibits histone deacetylases, changing chromatin structure and potentially affecting Zfp469 access to DNA. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Inhibits histone deacetylases, which may alter Zfp469 interactions with chromatin. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Interferes with DNA replication and transcription by intercalating into DNA, which can affect Zfp469's function. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
Binds to GC-rich sequences in DNA, potentially blocking Zfp469 binding sites. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Interacts with DNA and inhibits RNA polymerase, which can disrupt Zfp469's transcriptional regulation. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
Inhibits RNA polymerase II, potentially affecting Zfp469's role in transcription. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
Inhibits DNA topoisomerase I, leading to altered DNA dynamics that can affect Zfp469. | ||||||
Quinomycin A | 512-64-1 | sc-202306 | 1 mg | $166.00 | 4 | |
A quinoxaline antibiotic that binds to DNA and can inhibit Zfp469 DNA binding. | ||||||
Daunorubicin hydrochloride | 23541-50-6 | sc-200921 sc-200921A sc-200921B sc-200921C | 10 mg 50 mg 250 mg 1 g | $105.00 $438.00 $837.00 $1569.00 | 4 | |
Interacts with DNA by intercalation and inhibits topoisomerase II, which can disrupt Zfp469's function. | ||||||